National Guideline Clearinghouse | BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.

full-text ►

National Guideline Clearinghouse | BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.


British Committee for Standards in Haematology

Guideline Title BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Bibliographic Source(s) Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014 Feb;24(1):8-20. [47 references] Guideline Status This is the current release of the guideline. This guideline updates a previous version: Parker J, Wray J, Gooch A, Robson S, Qureshi H. Guidelines for the use of prophylactic anti-D immunoglobulin. London (UK): British Committee for Standards in Haematology (BCSH); 2006. 13 p. [21 references]